Abstract:Abstract Arsenite exposure is associated with an increased risk of lung cancers. Although efforts have been made, the precise mechanisms of the arsenite-induced lung carcinogenesis remain enigmatic. Aberrant cyclin D1 expression is an early event in carcinogenesis often accompanies human malignancies in the lung. Our previous study has shown that arsenite was able to induce cyclin D1 expression in human keratinocyte HaCat and mouse epidermal Cl41 cells to promote cell cycle transition, cell proliferation and transformation, which accounts for its ability to induce skin carcinogenesis. However, the role of Cyclin D1 underlying the arsenite-induced human lung carcinogenesis remain elusive. In the present study, arsenite exposure induced the cell cycle transition, resulting in growth promotion of human bronchial epithelial cells. The promoter activity and the expression of cyclin D1 were augmented in response to arsenite treatment. To further evaluate the effect of cyclin D1 in arsenite-induced cell proliferation, a cyclin D1 siRNA construct was stably introduced into Beas-2B cells. The siRNA blocked the induction/expression of cyclin D1. It has been reported that JNKs mediate the cyclin D1 expression in hematopoietic cells. Therefore, we investigated the potential contribution of JNKs to cyclin D1 expression induced by arsenite. Our results strongly suggest that JNK1 is a major kinase responsible for maintaining the basal level of C-Jun phosphorylation, and both JNK1 and JNK2 are critical for arsenite-induced C-Jun phosphorylation. Moreover, using a loss of function mutant Dp85 or DN-Akt, we demonstrated that the PI-3K/Akt pathway was involved in arsenite-induced upregulation of cyclin D1 and cell proliferation. The introduction of Dp85 or DN-Akt into the cells also inhibited JNKs activation as well as c-Jun phosphorylation, while the growth promotion induced by arsenite was significantly inhibited by the PI3K inhibitor Ly294002 and JNK inhibitor, or by over expression of DN-Akt. Overall, our data suggest a signaling pathway of PI-3K/Akt/JNK/c-Jun/cylin D1 signaling in response to arsenite in human bronchial epithelial cells, which leading to the growth promotion. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 4371.

Cyclooxygenase-2 induction by arsenite is through a nuclear factor of activated T-cell-dependent pathway and plays an antiapoptotic role in Beas-2B cells.

Sodium Arsenite Induces Cyclooxygenase-2 Expression in Human Uroepithelial Cells Through MAPK Pathway Activation and Reactive Oxygen Species Induction

Inflammatory cytokine COX-2 mediated cell proliferation through increasing cyclin D1 expression induced by inorganic arsenic in SV-HUC-1 human uroepithelial cells

Arsenic Induces the Expressions of Angiogenesis-Related Factors Through PI3K and MAPK Pathways in SV-HUC-1 Human Uroepithelial Cells.

Cyclooxygenase-2 (COX-2) Mediates Arsenite Inhibition of UVB-induced Cellular Apoptosis in Mouse Epidermal Cl41 Cells.

Arsenite Increases Cyclin D1 Expression Through Coordinated Regulation of the Ca2+/NFAT2 and NF-κB Pathways Via ERK/MAPK in a Human Uroepithelial Cell Line.

Arsenite-induced Downregulation of Occludin in Mouse Lungs and BEAS-2B Cells Via the ROS/ERK/ELK1/MLCK and ROS/p38 MAPK Signaling Pathways

Low concentration arsenite activated JAK2/STAT3 signal and increased proliferative factor expressions in SV-HUC-1cells after short and long time treatment.

ATF2 Partly Mediated the Expressions of Proliferative Factors and Inhibited Pro-Inflammatory Factors' Secretion in Arsenite-Treated Human Uroepithelial Cells.

Abstract 4371: PI3K/Akt/JNK/c-Jun Signaling Pathway is a Mediator for Arsenite-Induced Cyclin D1 Expression and Cell Growth in Human Bronchial Epithelial Cells

Pi3k/Akt/Jnk/C-Jun Signaling Pathway Is A Mediator For Arsenite-Induced Cyclin D1 Expression And Cell Growth In Human Bronchial Epithelial Cells

Arsenic trioxide induces expression of BCL-2 expression via NF-κB and p38 MAPK signaling pathways in BEAS-2B cells during apoptosis

Sustained high expression of NRF2 and its target genes induces dysregulation of cellular proliferation and apoptosis is associated with arsenite-induced malignant transformation of human bronchial epithelial cells

Continuous activation of Nrf2 and its target antioxidant enzymes leads to arsenite-induced malignant transformation of human bronchial epithelial cells

AP-1 Activation Attenuates the Arsenite-Induced Apoptotic Response in Human Bronchial Epithelial Cells by Up-Regulating HO-1 Expression

Opposed Arsenite-Induced Signaling Pathways Promote Cell Proliferation or Apoptosis in Cultured Lung Cells.

Arsenic trioxide promotes ERK1/2-mediated phosphorylation and degradation of BIMEL to attenuate apoptosis in BEAS-2B cells

Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells

Arsenic induces bronchial epithelial carcinogenesis with mitochondrial dysfunction through AKAP95-mediated cell cycle alterations

Nickel Compounds Render Anti-apoptotic Effect to Human Bronchial Epithelial Beas-2B Cells by Induction of Cyclooxygenase-2 through an IKKβ/p65-dependent and IKKα- and p50-independent Pathway

Arsenic Induced Overexpression of Inflammatory Cytokines Based on the Human Urothelial Cell Model in Vitro and Urinary Secretion of Individuals Chronically Exposed to Arsenic